STAT June 5, 2020
Eric M. Stone

Even as the health care industry has stepped up with an unprecedented response to the Covid-19 pandemic, health care companies are being undermined by a loss of revenue, splintering of their clinical workforces, and the disintegration of normal as we know it. For health-related entrepreneurs and startups, this means the rules of engagement with their stakeholders, including venture investors, are also changing. The emergence of a new abnormal will depend on several factors.

Is money available?

The message from the venture capital community is that it’s open for business. Firms say they are being more cautious but are still willing to invest. A few venture outfits have even closed new funds within the last weeks.

The truth for entrepreneurs and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Investments, Provider, Public Health / COVID, Technology, Trends
Uniquity Bio emerges with $300m for MSD immunology drug
Providence expands critical care access in Portland with $177M investment
HCA Healthcare UK expands network with £18m investment in dedicated women's health centres
Xaira Therapeutics Launches with $1 Billion in Funding and Stellar Team
Blackstone unsheathes Uniquity Bio with $300M

Share This Article